Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Biodefense Market In 2029?

In the past few years, we’ve seen significant growth in the biodefense market. The market, which was valued at $18.55 billion in 2024, is predicted to increase to $20.29 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. This growth during the historic period can be linked to factors such as the increase in government investment in biodefense programs and initiatives, the strengthening of regulatory frameworks to expedite the approval of biodefense products and technologies, improved collaboration among government agencies, private enterprises, and academic institutions, and heightened concerns about geopolitical tensions and bioterrorism.

What Growth Rate Is Forecasted for the Biodefense Market by 2029?

In the coming years, robust expansion is predicted for the biodefense market, which is projected to reach $28.75 billion by 2029 with a compound annual growth rate (CAGR) of 9.1%. This growth trend in the projection period can be credited to several factors including the consistent emergence of new infectious diseases, advancing biotechnology, enhancement of international cooperation and resource allocation for supporting global biodefense efforts, development and enhancement of biodefense facilities, raised public knowledge and education about biodefense, continued progression of policy and legal frameworks to facilitate innovative biodefense technologies, and an increase in investments from the private sector into biodefense R&D. The forecast period will be characterized by major trends such as the application of AI and machine learning for predictive analytics, risk detection, and the creation of fresh biodefense tactics, incorporation of telehealth and distant monitoring technologies for early detection and management of bio-threats, emphasis on producing next-gen vaccines and therapeutics, using AI to streamline drug discovery and development, and enhancing genomic surveillance and data analysis.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15993&type=smp

Which Key Companies Are Shaping the Future of the Biodefense Market?

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

Which Factors Are Driving Demand in the Biodefense Industry?

The growth of the biodefense market is predicted to be spurred on by the recurring menace of emerging infectious diseases. These diseases come about due to pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can move directly or indirectly from one individual to another. The recurring threat of emerging infectious diseases underscores the escalating issues posed by pathogens, swift response, global coordination, and readiness in biodefense. In managing infectious diseases, biodefense is integral by improving readiness, early recognition, and quick response to biological threats, thereby reducing the impact of outbreaks on public health. For instance, in November 2023, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations tasked with international public health, projected that around the world, there will be approximately 10.6 million tuberculosis (TB) cases in 2022, impacting around 5.8 million men, 3.5 million women, and 1.3 million children. As such, the repeating threat of infectious diseases is stimulating the growth of the biodefense market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15993&type=smp

How Is the Biodefense Market Segmented by Several Divisions?

The biodefense market covered in this report is segmented –

1) By Type: Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types

2) By Biothreat Detection Device: Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices

3) By Application: Hospitals And Clinics, Ambulatory Care Centers, Other Applications

Subsegments:

1) By Anthrax: Bacillus Anthracis Vaccine, Anthrax Therapeutics

2) By Smallpox: Smallpox Vaccine, Antiviral Drugs For Smallpox

3) By Botulism: Botulism Antitoxin, Botulism Vaccine, Botulinum Neurotoxin Inhibitors

4) By Radiation Or Nuclear: Radiation Protection Drugs, Medical Countermeasures

5) By Other Types: Ricin, Plague, Tularemia, Viral Hemorrhagic Fevers, Other Biotoxins Or Biothreat Agents

What are the Emerging Market Trends Driving the Growth of the Biodefense Industry?

Leading corporations in the biodefense sector are concentrating their efforts on creating groundbreaking solutions, like nasal vaccines for COVID-19, to improve worldwide readiness against biological threats. The use of nasal vaccines enhances biodefense by providing simpler administration, possible mucosal immunity, decreasing dependency on needles, boosting accessibility, and potentially reinforcing immune response. In January 2023, for example, Bharat Biotech International Limited, a biotech firm from India, rolled out the iNCOVACC Nasal COVID-19 vaccine. This vaccine, developed with a recombinant, replication-deficient adenovirus vector and including a pre-fusion stabilized spike protein, was designed for intranasal delivery via nasal drops after successfully passing phase I, II, and III clinical trials. It’s dispensed as a nasal drop, totalling 8 drops (0.5 mL per dose) with 4 drops applied to each nostril, given as a series of 2 doses administered 4 weeks apart.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biodefense-global-market-report

Which Regions Are Driving Growth in the Biodefense Market?

North America was the largest region in the biodefense market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15993

This Report Delivers Insight On:

1. How big is the biodefense market, and how is it changing globally?

2. Who are the major companies in the biodefense market, and how are they performing?

3. What are the key opportunities and risks in the biodefense market right now?

4. Which products or customer segments are growing the most in the biodefense market?

5. What factors are helping or slowing down the growth of the biodefense market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model